Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
20.9%
% of XPH's 43 holdings also in SBIO
10.0%
% of SBIO's 90 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XPH |
Weight in SBIO |
Overlap | |
---|---|---|---|---|
CORCEPT THERAPEUTICS INC | 4.2% | 3.1% | 3.1% | |
EDGEWISE THERAPEUTICS, INC. | 3.4% | 1.9% | 1.9% | |
ARVINAS, INC. | 2.7% | 1.2% | 1.2% | |
NEUMORA THERAPEUTICS, INC. | 1.1% | 1.6% | 1.1% | |
TARSUS PHARMACEUTICALS, INC. | 2.2% | 0.9% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to SBIO
BRISTOL-MYERS SQUIBB CO | 3.8% | |
CATALENT INC | 3.6% | |
ROYALTY PHARMA PLC CLASS A | 3.6% | |
ELI LILLY & CO | 3.6% | |
INTRA-CELLULAR THERAPIES INC | 3.6% | |
JAZZ PHARMACEUTICALS PLC | 3.6% | |
PFIZER INC | 3.5% | |
ZOETIS INC | 3.5% | |
ELANCO ANIMAL HEALTH, INC. | 3.5% | |
VIATRIS, INC. | 3.5% |
XPH Underweight Relative to SBIO
AVIDITY BIOSCIENCES INC | -3.5% | |
KRYSTAL BIOTECH, INC. | -3.4% | |
ALKERMES PLC | -3.1% | |
ARCELLX, INC. | -3.0% | |
CRINETICS PHARMACEUTICALS INC | -2.8% | |
DENALI THERAPEUTICS INC. | -2.5% | |
MERUS N.V. | -2.4% | |
AMICUS THERAPEUTICS INC | -2.0% | |
PTC THERAPEUTICS INC | -1.9% | |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -1.8% |